Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Cancer mortality in patients with schizophrenia: systematic review and meta-analysis

  • Chuanjun Zhuo, Ran Tao, Ronghuan Jiang, Xiaodong Lin, Mingjing Shao
  • Journal: The British Journal of Psychiatry / Volume 211 / Issue 1 / July 2017
  • Published online by Cambridge University Press: 02 January 2018, pp. 7-13
  • Print publication: July 2017
    • Article
      • You have access
    • PDF
    • HTML
    • Export citation
  • Background

    Previous studies have reported conflicting results on the association between schizophrenia and cancer mortality.

    Aims

    To summarise available evidence and quantify the association between schizophrenia and cancer mortality using meta-analysis.

    Method

    We systematically searched literature in the PubMed and Embase databases. Risk estimates and 95% confidence intervals reported in individual studies were pooled using the DerSimonian–Laird random-effects model.

    Results

    We included 19 studies in the meta-analysis. Among them, 15 studies reported standardised mortality ratios (SMRs) comparing patients with schizophrenia with the general population, and the pooled SMR was 1.40 (95% CI 1.29–1.52, P<0.001). The other four studies reported hazard ratios (HRs) comparing individuals with schizophrenia with those without schizophrenia; the pooled HR was 1.51 (95% CI 1.13–2.03, P = 0.006).

    Conclusions

    Patients with schizophrenia are at a significantly increased risk of cancer mortality compared with the general population or individuals without schizophrenia.